Polycythemia vera (PV) is a myeloproliferative neoplasm characterized by elevated hemoglobin and hematocrit levels, most commonly driven by constitutive activation of the JAK2 signaling pathway [3]. This evidence concerns the gene JAK2 and acquired polycythemia vera.